Vaccines and Therapeutics

6 01, 2021

Are COVID-19 vaccines a rush job? Explaining the speed of vaccine development

By |2021-02-12T00:09:34-05:00January 6th, 2021|Vaccines and Therapeutics|0 Comments

It turns out that things may not be as they appear when it comes to the speed of COVID-19 vaccine development. The reality is that COVID-19 vaccines are based on years of documented research that created the critical knowledge, infrastructure, and cutting-edge technology that made rapid vaccine production possible.

24 11, 2020

Vaccination Opponents Drive An Epidemic Of COVID-19 Misinformation

By |2021-02-16T17:28:24-05:00November 24th, 2020|Vaccines and Therapeutics|0 Comments

There is a saying that when all you have is a hammer, everything looks like a nail. So, it should come as no surprise that vaccine skeptics worldwide are sounding the alarm about the flu shot as a real danger in the COVID-19 pandemic. Confused? Well, it turns out the anti-vaccine activists are too.

19 10, 2020

Regeneron Antibodies: Fact-Checking the Science of an Experimental COVID-19 Treatment

By |2021-02-16T17:22:06-05:00October 19th, 2020|Vaccines and Therapeutics|0 Comments

In January, 2020, during the earliest days of the COVID-19 pandemic, a US-based research scientist was exposed to SARS-CoV-2, the virus responsible for the disease, at a family gathering in Beijing. Within months, samples provided by this anonymous scientist helped to kick-start research in antibody-based treatments for COVID-19 that ultimately lead to an experimental antibody treatment received by US President Donald Trump.

11 09, 2020

Towards a massive screening of COVID-19? The EasyCOV saliva test

By |2021-02-12T00:21:49-05:00September 11th, 2020|Vaccines and Therapeutics|0 Comments

"Test, test, test" has been the leitmotif of the World Health Organization (WHO) since the start of the pandemic. However, mass screening requires a rapid, simple and effective detection test. To answer this question, french researchers carried out a real race against the clock in the laboratory in order to produce and market this test in record time. This one, called EasyCOV1, requires a saliva sample and provides the results in 1 hour. Back on this test and its mode of action.

11 09, 2020

What is this promising COVID-19 vaccine developed by Moderna?

By |2021-02-12T13:52:44-05:00September 11th, 2020|Vaccines and Therapeutics|0 Comments

In mid-May, the American company Moderna announced that the vaccine developed against Covid-19 had triggered an immune response in 8 patients. These patients secreted antibodies in an amount comparable to those seen in infected patients and recovered from the coronavirus. Among the panoply of vaccine strategies currently being tested, to which category does Moderna belong?

17 07, 2020

The Ups and Downs of Hydroxychloroquine

By |2021-02-12T00:25:11-05:00July 17th, 2020|Vaccines and Therapeutics|0 Comments

As COVID19 continues to spread, the global search for a cure is underway. The development of a preventative vaccine is likely months if not a year away. In the meantime, several therapies have been raised as potential cures with hydroxychloroquine arguably being the most widely known. But will this miracle treatment live up to the hype?

Go to Top